Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.09 (overall 0.12) | 0.09 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 37 Parkinson's papers of 268 | 0.52 |
| pathways Reactome | 2 pathways; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 2324
Sealed predictions
- SCARB2 in dopamine neurons, braak-0.02 (p 0.964) → +0.56 (p 0.114)receipt 2329
In the sealed studies
- The lysosomal axis in dopamine neurons: did not hold
Swarm cases
receipt 2329: SCARB2 in dopamine neurons, braak
- power
- full sample +0.28 (p 0.254, n 18), 95% CI -0.21 to +0.66. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.30 (p 0.228, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.29 (p 0.250, n 18). could be the mix.
- skeptic
- leave-one-out range +0.19 to +0.46, sign flips 0; without severely affected donors +0.28 (p 0.254, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SCARB2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts